SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledMarch 27th, 2018 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 21, 2018, is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (“Company”), and CHICAGO VENTURE PARTNERS, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 2nd, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledMarch 2nd, 2018 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 26, 2018, is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (“Company”), and CHICAGO VENTURE PARTNERS, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 14th, 2017 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledDecember 14th, 2017 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 8, 2017, is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (“Company”), and CHICAGO VENTURE PARTNERS, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).